Highly Emissive Dye-Sensitized Upconversion Nanostructure for Dual-Photosensitizer Photodynamic Therapy and Bioimaging.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28320205.
- Also identified by DOI 10.1021/acsnano.7b00944.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Rare-earth-based upconversion nanotechnology has recently shown great promise for photodynamic therapy (PDT). However, the NIR-induced PDT is greatly restricted by overheating issues on normal bodies and low yields of reactive oxygen species (ROS, <sup>1</sup>O<sub>2</sub>). Here, IR-808-sensitized upconversion nanoparticles (NaGdF<sub>4</sub>:Yb,Er@NaGdF<sub>4</sub>:Nd,Yb) were combined with mesoporous silica, which has Ce6 (red-light-excited photosensitizer) and MC540 (green-light-excited photosensitizer) loaded inside through covalent bond and electrostatic interaction, respectively. When irradiated by tissue-penetrable 808 nm light, the IR-808 greatly absorb 808 nm photons and then emit a broadband peak which overlaps perfectly with the absorption of Nd<sup>3+</sup> and Yb<sup>3+</sup>. Thereafter, the Nd<sup>3+</sup>/Yb<sup>3+</sup> incorporated shell synergistically captures the emitted NIR photons to illuminate NaGdF<sub>4</sub>:Yb,Er zone and then radiate ultrabright green and red emissions. The visible emissions simultaneously activate the dual-photosensitizer to produce a large amount of ROS and, importantly, low heating effects. The in vitro and in vivo experiments indicate that the dual-photosensitizer nanostructure has trimodal (UCL/CT/MRI) imaging functions and high anticancer effectiveness, suggesting its potential clinical application as an imaging-guided PDT technique.
Medical subject headings
- Antineoplastic Agents
- Metal Nanoparticles
- Metals, Rare Earth
- Neoplasms